Concepedia

Wence Agbotounou

WA

Statistics

Publications

3

Citations

57

H-Index

3

Active since

2013

Affiliations

DBV Technologies (France)(Current)

Icahn School of Medicine at Mount Sinai

Hôpital Necker-Enfants Malades

Wence Agbotounou is an author at DBV Technologies (France) specializing in childhood food allergy, allergy medicine, and allergy.

Top concepts

Publications per year

2013–2016

3

Publications

3

Epicutaneous Immunotherapy (EPIT) Is Effective and Safe to Treat Peanut Allergy: A Multi-National Double-Blind Placebo-Controlled Randomized Phase IIb Trial

Hugh A. Sampson, Wence Agbotounou, Claude Thébault et al. · Journal of Allergy and Clinical Immunology · 2015 · 29 citations

, , +13

Epicutaneous Immunotherapy (EPIT) Is Safe for the Treatment of Peanut Allergy in Allergic Patients

Wence Agbotounou, Laurent Martin, B. Dupont et al. · Journal of Allergy and Clinical Immunology · 2013 · 18 citations

, , +12

Safety of Viaskin Milk Epicutaneous Immunotherapy (EPIT) in IgE-Mediated Cow's Milk Allergy (CMA) in Children (MILES Study)

Karine Rutault, Wence Agbotounou, Aurélie Peillon et al. · Journal of Allergy and Clinical Immunology · 2016 · 10 citations

, , +9

1–3 of 3